Xencor reported $0 in Loan Capital for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Alexion Pharmaceuticals ALXN:US $ 2388.8M 30.8M
Alnylam Pharmaceuticals ALNY:US $ 433.8M 0.65M
Amgen AMGN:US $ 33291M 4833M
Arrowhead Research ARWR:US $ 0 0
AstraZeneca AZN:LN 28939M 4338M
Biogen BIIB:US $ 6272.3M 996.9M
Bristol Myers Squibb BMY:US $ 39677M 2826M
Cytokinetics CYTK:US $ 124.09M 3.8M
Epizyme EPZM:US $ 231.83M 640K
GlaxoSmithKline GSK:LN 20736M 294M
Karyopharm Therapeutics KPTI:US $ 301.57M 195K
Macrogenics MGNX:US $ 0 0
Novartis NOVN:VX SF 24715M 1776M
Regeneron Pharmaceuticals REGN:US $ 1979.6M 0.4M
Seattle Genetics SGEN:US $ 0M 0M
Xencor XNCR:US $ 0M 0M